Primary references
Sources & Update Notes
This source library lists the primary webpages used to support LevelsRx program facts, GLP-1 regulatory context, insurance notes and affiliate disclosures.
LevelsRx program source
- Official LevelsRx website — program model, advertised prices, medication options, FAQs, clinician evaluation, delivery and insurance statements. Last checked August 16, 2026.
FDA medication and compounding sources
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — compounded-product warnings, dosing errors, fraudulent products and salt-form concerns.
- FDA: Wegovy / semaglutide approval context.
- FDA: Zepbound / tirzepatide approval for chronic weight management.
Insurance source
- Medicare.gov: Weight loss drugs — current Medicare coverage information for eligible beneficiaries.
Affiliate disclosure source
- FTC Endorsement Guides FAQ — guidance on clear and conspicuous affiliate disclosures.
- FTC Health Products Compliance Guidance — health-advertising substantiation principles.
How to use this page
Use the official provider site for the latest LevelsRx commercial terms. Use FDA and insurer/government pages for regulatory and benefit questions. This guide can summarize those relationships, but it should not replace the primary source when a decision depends on current facts.